Prabhu Kirti S, Lobo Richard, Shirwaikar Annie
Department of Pharmacognosy, Manipal College of Pharmaceutical Science, Manipal, India.
J Pharm Pharmacol. 2008 Jul;60(7):909-16. doi: 10.1211/jpp.60.7.0013.
We have investigated the possible antihyperglycaemic effects of Sphaeranthus indicus extract in rats rendered diabetic by nicotinamide (120 mgkg(-1) i.p.) and streptozotocin (STZ) (60 mgkg(-1) i.p). Fasting plasma glucose levels, serum insulin levels, serum lipid profiles, magnesium levels, glycosylated haemoglobin, changes in body weight and liver glycogen levels were evaluated in normal and diabetic rats. Oral administration of S. indicus for 15 days resulted in significant decrease in blood glucose levels and increases in hepatic glycogen and plasma insulin levels. Fasting normal rats treated with the alcoholic extract of S. indicus showed significant improvement in oral glucose tolerance test. Glibenclamide was used as a reference standard. The findings demonstrate that the alcoholic S. indicus extract may be useful in the treatment of diabetes.
我们研究了印度圆叶薄荷提取物对通过烟酰胺(120毫克/千克腹腔注射)和链脲佐菌素(STZ)(60毫克/千克腹腔注射)诱导糖尿病的大鼠可能具有的降血糖作用。对正常大鼠和糖尿病大鼠评估了空腹血糖水平、血清胰岛素水平、血清脂质谱、镁水平、糖化血红蛋白、体重变化和肝糖原水平。口服印度圆叶薄荷15天导致血糖水平显著降低,肝糖原和血浆胰岛素水平升高。用印度圆叶薄荷醇提取物处理的空腹正常大鼠在口服葡萄糖耐量试验中显示出显著改善。格列本脲用作参考标准。研究结果表明,印度圆叶薄荷醇提取物可能对糖尿病治疗有用。